Your browser doesn't support javascript.
loading
PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma Tumor Models to Antiangiogenic Tyrosine Kinase Inhibitors.
Stokes, Michael E; Calvo, Veronica; Fujisawa, Sho; Dudgeon, Crissy; Huang, Sharon; Ballal, Nupur; Shen, Leyi; Gasparek, Jennifer; Betzenhauser, Matthew; Taylor, Simon J; Staschke, Kirk A; Rigby, Alan C; Mulvihill, Mark J; Bose, Nandita; Lightcap, Eric S; Surguladze, David.
  • Stokes ME; HiberCell, Inc., New York City, New York.
  • Calvo V; HiberCell, Inc., New York City, New York.
  • Fujisawa S; HiberCell, Inc., New York City, New York.
  • Dudgeon C; HiberCell, Inc., New York City, New York.
  • Huang S; HiberCell, Inc., New York City, New York.
  • Ballal N; HiberCell, Inc., New York City, New York.
  • Shen L; HiberCell, Inc., New York City, New York.
  • Gasparek J; Curia, Buffalo, New York.
  • Betzenhauser M; Curia, Buffalo, New York.
  • Taylor SJ; Drug Discovery, Pharmaron UK Ltd., Hoddesdon, Herts, United Kingdom.
  • Staschke KA; Indiana University School of Medicine, Indianapolis, Indiana.
  • Rigby AC; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana.
  • Mulvihill MJ; HiberCell, Inc., New York City, New York.
  • Bose N; HiberCell, Inc., New York City, New York.
  • Lightcap ES; HiberCell, Inc., New York City, New York.
  • Surguladze D; HiberCell, Inc., New York City, New York.
Clin Cancer Res ; 29(23): 4870-4882, 2023 12 01.
Article en En | MEDLINE | ID: mdl-37733811
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2023 Tipo del documento: Article